HAVCR2 and neoplasm: The aptamer selected by HT-SELEX had an affinity of 22 nM and was able to block TIM3, enhancing T-cell activation and reducing the tumor load in a colon carcinoma CT26 orthotropic tumor model in combination with anti-PDL1 antibodies [39].